3-(1-Methyl-1H-pyrazol-5-yl)isoxazol-5-amine, 98%, 100mg

1-(3,5-dimethylphenyl)piperidin-4-one, 95.0%, 1g

ethyl (2Z)-2-chloro-2-[2-(2-methyl-4-nitrophenyl)hydrazin-1-ylidene]acetate, 95.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-sulfopropanoic acid, 97.0%, 500g

Colonna capillare per GC ROTI®Cap-1, 50 m, 0,20 mm, 0,35 µm, 1 Pezzo(i)

(2-Methylquinolin-5-yl)boronic acid, 98+%, 100mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 250mg

5-Bromo-2-fluorobenzonitrile>98.0%(GC)5g

1-(1H-Indazol-6-yl)ethanone, 95.0%, 250mg

1-(3-AMINOPROPYL)-3-PHENYLUREA HCL, 95.0%, 100mg

3-(4-Bromophenyl)-5-chloroisoxazole, 5g

Methyl 4-oxotetrahydro-2H-thiopyran-3-carboxylate, 95.0%, 250mg

Pyrazin-2-ylmethanamine hydrochloride, 95.0%, 25g